tiprankstipranks
Trending News
More News >
Sunshine Biopharma, Inc. (SBFM)
:SBFM
US Market

Sunshine Biopharma (SBFM) Ratios

Compare
406 Followers

Sunshine Biopharma Ratios

SBFM's free cash flow for Q4 2024 was $0.33. For the 2024 fiscal year, SBFM's free cash flow was decreased by $ and operating cash flow was $-0.24. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
4.11 4.48 3.94 24.07 0.98
Quick Ratio
2.33 3.45 3.47 22.91 0.95
Cash Ratio
1.53 2.93 3.15 22.42 0.94
Solvency Ratio
-0.70 -0.71 -3.51 -6.40 -0.44
Operating Cash Flow Ratio
-1.98 -1.58 -0.76 -20.05 -0.63
Short-Term Operating Cash Flow Coverage
0.00 0.00 -1.45 0.00 -0.68
Net Current Asset Value
$ 18.91M$ 18.75M$ 19.70M$ 204.60K$ -974.37K
Leverage Ratios
Debt-to-Assets Ratio
0.03 0.02 0.15 0.86 1.83
Debt-to-Equity Ratio
0.04 0.03 0.20 8.98 -2.00
Debt-to-Capital Ratio
0.04 0.03 0.17 0.90 2.00
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.90 -162.75
Financial Leverage Ratio
1.30 1.29 1.35 10.41 -1.09
Debt Service Coverage Ratio
-560.68 -30.73 -7.27 -37.78 -0.63
Interest Coverage Ratio
-662.43 -34.85 -220.09 -7.42 -3.43
Debt to Market Cap
0.00 0.00 0.37 0.25 1.41
Interest Debt Per Share
1.37 65.35 568.33 1.71K 2.40K
Net Debt to EBITDA
1.69 4.09 0.66 0.01 -0.35
Profitability Margins
Gross Profit Margin
30.60%34.61%39.04%48.42%63.80%
EBIT Margin
-15.42%-16.49%-609.16%-5300.46%-3663.33%
EBITDA Margin
-14.78%-15.87%-608.58%-5294.88%-3643.64%
Operating Profit Margin
-16.67%-19.86%-199.60%-1068.24%-807.83%
Pretax Profit Margin
-15.40%-17.06%-610.07%-5444.41%-3898.74%
Net Profit Margin
-14.72%-18.70%-615.44%-5588.36%-1257.08%
Continuous Operations Profit Margin
-14.72%-18.70%-615.44%-5444.41%-3898.74%
Net Income Per EBT
95.63%109.61%100.88%102.64%32.24%
EBT Per EBIT
92.38%85.91%305.64%509.66%482.62%
Return on Assets (ROA)
-16.80%-16.48%-91.45%-579.48%-85.86%
Return on Equity (ROE)
-21.85%-21.25%-123.66%-6030.97%94.01%
Return on Capital Employed (ROCE)
-23.97%-21.96%-38.87%-115.56%9893.23%
Return on Invested Capital (ROIC)
-22.73%-23.94%-33.57%-118.61%-19.41%
Return on Tangible Assets
-18.64%-17.40%-93.95%-579.48%-85.86%
Earnings Yield
-243.87%-68.22%-275.28%-167.23%-66.02%
Efficiency Ratios
Receivables Turnover
9.02 9.44 2.27 29.29 37.27
Payables Turnover
4.37 6.09 0.95 2.74 0.41
Inventory Turnover
2.15 2.75 0.81 1.12 1.09
Fixed Asset Turnover
23.53 23.79 3.76 32.35 3.66
Asset Turnover
1.14 0.88 0.15 0.10 0.07
Working Capital Turnover Ratio
1.79 1.21 0.39 0.22 -0.18
Cash Conversion Cycle
126.97 111.63 227.73 206.71 -542.35
Days of Sales Outstanding
40.49 38.67 160.61 12.46 9.79
Days of Inventory Outstanding
170.07 132.87 453.31 327.27 335.68
Days of Payables Outstanding
83.59 59.90 386.19 133.02 887.82
Operating Cycle
210.56 171.54 613.92 339.73 345.48
Cash Flow Ratios
Operating Cash Flow Per Share
-17.86 -721.34 -691.48 -1.40K -759.01
Free Cash Flow Per Share
-21.16 -786.12 -731.67 -1.40K -760.38
CapEx Per Share
3.31 64.78 40.18 0.00 1.38
Free Cash Flow to Operating Cash Flow
1.19 1.09 1.06 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
-5.40 -11.13 -17.21 0.00 -551.89
Capital Expenditure Coverage Ratio
-5.40 -11.13 -17.21 0.00 -551.89
Operating Cash Flow Coverage Ratio
-13.16 -13.34 -1.23 -0.96 -0.34
Operating Cash Flow to Sales Ratio
-0.36 -0.36 -1.21 -8.01 -9.20
Free Cash Flow Yield
-705.48%-144.77%-57.16%-23.96%-48.43%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-0.41 -1.47 -0.36 -0.60 -1.51
Price-to-Sales (P/S) Ratio
0.06 0.27 2.24 33.42 19.04
Price-to-Book (P/B) Ratio
0.09 0.31 0.45 36.06 -1.42
Price-to-Free Cash Flow (P/FCF) Ratio
-0.14 -0.69 -1.75 -4.17 -2.06
Price-to-Operating Cash Flow Ratio
-0.17 -0.75 -1.85 -4.17 -2.07
Price-to-Earnings Growth (PEG) Ratio
<0.01 0.02 <0.01 >-0.01 -0.06
Price-to-Fair Value
0.09 0.31 0.45 36.06 -1.42
Enterprise Value Multiple
1.29 2.36 0.30 -0.62 -0.88
Enterprise Value
-6.63M -9.03M -7.84M 7.49M 2.28M
EV to EBITDA
1.29 2.36 0.30 -0.62 -0.88
EV to Sales
-0.19 -0.37 -1.80 32.78 31.97
EV to Free Cash Flow
0.45 0.94 1.41 -4.09 -3.47
EV to Operating Cash Flow
0.53 1.03 1.49 -4.09 -3.47
Tangible Book Value Per Share
29.19 1.62K 2.75K 162.07 -1.10K
Shareholders’ Equity Per Share
33.49 1.74K 2.85K 162.07 -1.10K
Tax and Other Ratios
Effective Tax Rate
0.04 -0.10 >-0.01 -0.03 0.68
Revenue Per Share
49.70 1.98K 572.54 174.91 82.46
Net Income Per Share
-7.32 -370.41 -3.52K -9.77K -1.04K
Tax Burden
0.96 1.10 1.01 1.03 0.32
Interest Burden
1.00 1.03 1.00 1.03 1.06
Research & Development to Revenue
0.00 0.08 0.19 2.94 0.85
SG&A to Revenue
0.40 0.42 2.05 8.17 7.67
Stock-Based Compensation to Revenue
0.00 0.00 0.00 4.02 0.70
Income Quality
2.44 1.95 0.20 0.15 0.24
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis